Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - AerCap Holdings (NYSE:AER), Canopy Growth (NASDAQ:CGC)

U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording gains in today’s pre-market trading session.

Acelyrin, Inc. (NASDAQ:SLRN) shares tumbled 58.5% to $11.58 in pre-market trading as the company said primary endpoint of HiSCR75 at week 16 did not meet statistical significance in non-responder imputation primary analysis.
Sight Sciences, Inc. (NASDAQ:SGHT) shares fell 29.3% to $4.60 in pre-market trading after the company issued third-quarter total revenue guidance below estimates and cut FY23 revenue guidance.
Oracle Corporation (NYSE:ORCL) shares dipped 9.3% to $114.90 in pre-market trading. Oracle reported upbeat earnings for its first quarter, while sales fell short of expectations.
Canopy Growth Corporation (NASDAQ:CGC) shares declined 9.5% to $1.53 in pre-market trading. Canopy Growth shares jumped 81% on Monday following the company's presentation at the Morgan Stanley 21st Annual Global Healthcare Conference 2023.
CS Disco, Inc. (NYSE:LAW) shares fell 8.2% to $8.70 in pre-market trading as the company said co-founder Kiwi Camara has decided to step down from his roles as CEO and member of board. The company named Scott Hill as interim CEO.
AerCap Holdings N.V. (NYSE:AER) shares fell 4.5% to $59.00 in pre-market trading. AerCap priced its secondary offering of 40.68 million ordinary shares by GE Capital US Holdings at $59 per share.
POSCO Holdings Inc. (NYSE:PKX) shares fell 4.1% to $103.80 in pre-market trading.
Tango Therapeutics, Inc. (NASDAQ:TNGX) shares declined 3.5% to $7.96 in pre-market trading after jumping 17% on Monday. The FDA recently cleared Tango Therapeutics' investigational new drug application for TNG348 for BRCA 1/2 mutant and other HRD+ (Homologous Recombination Deficient) cancers.